The Bacterial Profile and Antibiotic Susceptibility Pattern in Respiratory Tract Samples from ART-Experienced HIV-Positive Adults in Uganda

Introduction

For over three decades, Human Immunodeficiency Virus (HIV) infection remains a disease of public health importance with approximately 37.6 million people living with HIV (PLWH) globally in 2020 (1). Sub-Saharan Africa (SSA) suffers the highest burden of HIV with nearly 70% of global HIV infections (2). Since the introduction of antiretroviral therapy (ART), PLWH have an improved quality of life however, microbial infections are still a major cause of morbidity and mortality among this population (3), with approximately 70% of illnesses being respiratory tract infections (RTIs) (4, 5). Ojha et al. reported a high prevalence (47%) of respiratory tract infections caused by bacterial pathogens among PLWH(5) and, factors associated with these infections include low CD4 counts (<200 cells/µl) and detectable viral loads (5, 6).

HIV infection causes a progressive depletion of CD4 T cells as well as an impairment of cellular and humoral immunity through a dysfunction of the T and B cells respectively (7). A dysfunction of T cells leads to abnormal cellular responses while a dysfunction of B cells leads to a lack of antibody responses to infections. The resultant immune dysfunction, deregulation and depletion of CD4 lymphocytes causes an increased susceptibility to infections and the subsequent risk of other complications like resistant pathogens (8, 9). HIV infection causes an alteration in lung host defences for example, it affects mucociliary function which may contribute to an increase RTIs among PLWH (9). PLWH are at increased risk of hospital acquired infections due to their frequent contact with health care system through frequent clinic visits and admissions (10). The frequent infections and admissions among PLWH, pill burden leading to unfinished doses and inappropriate use of drugs through self-medication are some of the factors that have led to the development of antimicrobial resistance among this population (11).

Antimicrobial resistance is an emerging global problem of public health importance (4). Previous studies have reported a much higher prevalence of drug resistant bacteria among PLWH (79%) compared to their HIV negative counterparts (30%) (10, 12). Prophylactic cotrimoxazole given to PLWH over prolonged periods of time to prevent opportunistic infections has been reported to give rise to antibiotic resistance (13). Resistant microbes are more difficult to manage since they require alternative medications and or higher doses of drugs, both of which are more expensive, not readily available in SSA and or toxic to the patient (13). Additionally, laboratory capacity for identifying AMR is still limited in many parts of SSA; data are therefore still limited on antimicrobial susceptibility patterns among PLWH in SSA (10). (10). It is important to understand the common disease-causing pathogens among PLWH and current antibiotic susceptibility patterns for better management. We studied the susceptibility pattern of microorganisms isolated from respiratory samples taken from PLWH in central Uganda.

Methods

Results

Bacterial culture positivity and prevalence of isolated microorganisms

A total of 201 (29.3%) samples had bacterial growth, with 9 samples growing more than one bacterial organism. Isolated bacteria included Moraxella species (55, 27.4%), Streptococcus pneumoniae (51, 25.4%), Haemophilus influenza (45, 22.4%), Mycobacterium species (11, 4.5%), Pseudomonas species (8, 4.0%), Staphylococcus aureus (8, 4.0%), Escherichia coli (2, 1.0%), Klebsiella species (2, 1.0%) and other bacteria (19, 10.4%) (Figure 1).

• Download figure
• Open in new tab

Fig.1 Frequency of bacterial isolates.

Discussion

We cultured sputum from ART experienced PLWH with a productive cough and approximately 30% of the sputum samples had bacterial growth. This is similar to what was reported by Akingbade OA et al who found a prevalence of 24.2% positive cultures from sputum collected from participants with lower RTIs (18), but lower than approximately 44% prevalence reported by Adhanom et al (19). Adhanom et al included both ART experienced and ART naïve participants that were suspected of pneumonia, which more a severe disease than the presentation of cough that was considered in our study. Our participants were all ART experienced, indicating they might have had a better immunity than those included in Adhanom et al study. Additionally, Adhanoum et al’s study was conducted in three years after the COSTOP study, during which period there might have been an increase in antimicrobial resistance, leading to reduced response by the bacteria to antibiotics hence increased bacterial growth on culture.

We found a high prevalence of Moraxella species (28%) in our sputum samples. Moraxella species is usually normal flora of the respiratory tract, however, previous studies have reported Moraxella as a pathogen of the lower respiratory tract in immunosuppressed patients (20). Abdullah et al reported a relatively high prevalence of Moraxella in patients with lower RTIs among the elderly and immunosuppressed (20). Our finding of high proportion of participants with Moraxella species may indicate a less than complete immune recovery in these patients. The Moraxella species isolated in our study was sensitive to amoxicillin+ clavulanic acid and ceftriaxone and had very low sensitivity to erythromycin and cotrimoxazole, which is similar to what Abdullah et al reported (20). The very low sensitivity of all the bacterial isolates to cotrimoxazole is not surprising since our study participants were either on active cotrimoxazole prophylaxis, or had previously used cotrimoxazole prophylaxis.

HIV infection leads to a low CD4 count and a defective immune system which renders people infected with the HIV virus susceptible to microbial infections leading to a greater use of antibiotics among people living with HIV. The increased use of antibiotics may explain the observed low sensitivity of isolated bacteria to cotrimoxazole (21), and erythromycin (20) among PLWH in this study and other studies.

Participants that received placebo were more likely to have a positive sputum culture compared to those receiving cotrimoxazole, however this was not statistically significant. This implies that use of Cotrimoxazole did not provide protection against respiratory infections in this study population. This could be due to the fact that the study participants were ART experienced, had improved and stabilised immunity, and thus were no longer susceptible to infections associated with compromised immunity. Although the study was not powered to answer the question on the effect of cotrimoxazole on respiratory bacterial infections, this finding supports the 2020 Uganda HIV prevention and treatment guidelines that recommends use of prophylactic cotrimoxazole only in adults with advanced HIV disease, those newly diagnosed with HIV, children below 18years, pregnant and breastfeeding women(22). An association of long term use of cotrimoxazole among PLWH with an increase in resistance to cotrimoxazole has been reported in previous studies (23, 24) therefore, reduced use of cotrimoxazole in this population may reduce resistance of microbes to it.

The participants in the study were generally low earners as majority of them were earning less than $30 a month. Participants who earned more than $30 were less likely to have positive bacterial cultures compared to those who earned less than $30. This is similar to evidence that suggests that those with lower socio-economic status are more vulnerable, have higher burden of disease and thus more prone to frequent respiratory infections (25).

Participants who had a longer duration since HIV diagnosis were more likely to have a positive bacterial culture. This finding requires further investigation since there is no clear biological explanation between duration of HIV infection and risk of bacterial infections.

Strengths and Limitations

This study among ART experienced participants has applicable results as majority of PLWH are on ART following the test and treat policy. Previous studies have mainly reported antimicrobial sensitivity among ART naïve patients. The study was however, a secondary data analysis and this limited the number of antimicrobial drugs that could have been tested for bacterial sensitivity. We could also not explore other factors for example viral load, that could be associated with a positive sputum culture.

Conclusion

High prevalence of bacterial isolates with most being susceptible to Amoxicillin + Clavulanic acid and ceftriaxone. However, majority of organisms showed very low sensitivity to cotrimoxazole and erythromycin that are cheaper and readily available. As antibiotic choices are becoming limited due to low sensitivity of microbes to these drugs, there is an urgent need to invest in the prevention and control of increasing antibiotic resistance.

Competing interests

The authors declare no competing interests.

Ethical approval statement

All participants enrolled into the main COSTOP trial gave written informed consent prior to any study procedures. The COSTOP study received approval from Uganda Virus Research Institute Ethics committee, National Drug Authority and Uganda National Council for Science and Technology.

Author Contributions

LG conceived and designed the study, participated in data collection, analysis and interpretation, AA contributed to data analysis. All authors read, revised the original manuscript and approved the final version of manuscript.